Search Results Search Sort by RelevanceMost Recent In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712. In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28. In the Literature May 2003 HIV Policy: Does Most Effective Equal Best? Susanna Smith Virtual Mentor. 2003;5(5):174-177. doi: 10.1001/virtualmentor.2003.5.5.jdsc2-0305. In the Literature Dec 2010 Evidence-Based Medicine: Can You Trust the Evidence? Yvonne M. Buys, MD In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time. Virtual Mentor. 2010;12(12):930-933. doi: 10.1001/virtualmentor.2010.12.12.jdsc1-1012.
In the Literature Dec 2007 Convincing Physicians to Report Communicable Diseases Sarah Lusk Virtual Mentor. 2007;9(12):811-813. doi: 10.1001/virtualmentor.2007.9.12.jdsc1-0712.
In the Literature Jan 2020 How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? Nicholas G. Evans, PhD, Kelly Hills, and Adam C. Levine, MD WHO suggests doing research during outbreaks but says little about local researchers’ access to samples or subjects’ access to what’s learned. AMA J Ethics. 2020;22(1):E28-35. doi: 10.1001/amajethics.2020.28.
In the Literature May 2003 HIV Policy: Does Most Effective Equal Best? Susanna Smith Virtual Mentor. 2003;5(5):174-177. doi: 10.1001/virtualmentor.2003.5.5.jdsc2-0305.
In the Literature Dec 2010 Evidence-Based Medicine: Can You Trust the Evidence? Yvonne M. Buys, MD In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time. Virtual Mentor. 2010;12(12):930-933. doi: 10.1001/virtualmentor.2010.12.12.jdsc1-1012.